ESTUTC-5 New YorkLog in Sign up

QNTM
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
stockNASDAQ

At CloseNov 6, 2026 3:59:44 PM EST

2.09USD-0.476%(-0.01)43,607

Pre-marketNov 6, 2026 9:06:30 AM EST

2.0923USD-0.367%(-0.0077)

QNTM News

Day breaks

05:00 PM ESTQuantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold ·

GlobeNewswire Inc.

03:00 PM ESTQuantum BioPharma (QNTM) Advances Broad Strategy Anchored by Science, Disciplined Growth ·

NewMediaWire

09:45 AM ESTQuantum BioPharma Ltd. (NASDAQ: QNTM) Advances Broad Strategy Anchored by Science, Disciplined Growth ·

NetworkNewsWire

03:30 PM ESTQuantum BioPharma (QNTM) Draws 'Men's Fitness' Spotlight as Unbuzzd Trial Shows Early Promise ·

NewMediaWire

10:30 AM ESTQuantum BioPharma Ltd. (NASDAQ: QNTM) Draws ‘Men’s Fitness’ Spotlight as Unbuzzd Trial Shows Early Promise ·

NetworkNewsWire

02:30 PM EDTQuantum BioPharma (QNTM) Featured in Men's Fitness Article Examining Unbuzzd Clinical Trial Results ·

NewMediaWire

08:00 AM EDTWorld Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares ·

GlobeNewswire Inc.

03:30 PM EDTQuantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial ·

NewMediaWire

09:30 AM EDTQuantum BioPharma Ltd. (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial ·

NetworkNewsWire

03:00 PM EDTQuantum BioPharma (QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial ·

NewMediaWire

01:00 PM EDTQuantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial ·

FinanceWire

06:00 AM EDTQuantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis ·

GlobeNewswire Inc.+2 sources

03:00 PM EDTQuantum BioPharma (QNTM) Receives FDA Green Light to Move Lucid-MS Into Phase 2 Testing ·

NewMediaWire

10:30 AM EDTQuantum BioPharma Ltd. (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing ·

NetworkNewsWire

08:04 AM EDTQuantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO ·

Financial Post

02:30 PM EDTQuantum BioPharma (QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments ·

NewMediaWire

10:30 AM EDTQuantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments ·

NetworkNewsWire

04:53 PM EDTQuantum BioPharma reports Q4 results ·

Seeking Alpha